Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.26
Delayed Data
As of 4:00pm ET
 +0.0011 / +0.42%
Today’s Change
0.21
Today|||52-Week Range
0.40
+4.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues161.0K213.0K150.0K197.0K
 
 
 
 
 
Cost of Goods Sold413.0K1.3M543.0K555.0K
 
 
 
 
 
Depreciation And Amortization630.0K683.0K691.0K696.0K
 
 
 
 
 
 
Operating ExpensesGross Income-882.0K-1.8M-1.1M-1.1M
 
 
 
 
 
General Expenses13.4M18.6M15.9M17.6M
 
 
 
 
 
Research And Development6.7M9.5M8.2M8.5M
 
 
 
 
 
Total Operating Expenses14.5M20.6M17.1M18.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.3M-20.3M-17.0M-18.7M
 
 
 
 
 
Extraordinary Credit2.5M94.0K281.0K14.0K
 
 
 
 
 
Extraordinary Charge0.000.00-976.0K-145.0K
 
 
 
Interest Expense On Debt41.0K24.0K159.0K11.0K
 
 
 
 
 
Other Expenses2.3M1.3M686.0K680.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.0M-17.4M-16.2M-17.5M
 
 
 
 
 
Net Income-9.0M-17.4M-16.2M-17.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS135.4M141.0M167.3M188.3M
 
 
 
 
 
Shares To Calculate EPS Diluted135.4M141.0M167.3M188.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.12-$0.10-$0.09
 
 
 
 
 
EPS Diluted-$0.07-$0.12-$0.10-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account